PIN Pharma PIN Pharma is a biopharmaceutical company focused on developing broad-base immuno-modulatory therapies, linking the innate and adaptive immune systems. | ![]() Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. | Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. | ![]() Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. | ||
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 2016 | Founding Date 2016 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ | Locations San Diego, US HQ Bryan, US | Locations Boston, US HQ | Locations Oxford, GB HQ | Locations Houston, US HQ |
Employees | Employees 1 | Employees 1630% decrease | Employees 5052% increase | Employees 33 | Employees 2 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.2 m | Valuation ($) 82.5 m | Valuation ($) 57.2 m | Valuation ($) 2.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $400k (FY, 2025) | Revenue (est.) $800k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income ($66.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 9.3m | Total funding raised $ 49m | Total funding raised $ 195.1m | Total funding raised N/A |

Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View companyBarinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases.
View company
Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View company